Attend this conference to get an insight into how molecular technologies are advancing the development of clinically useful diagnostic tests for infectious diseases in humans, animals and plants both in developed and developing worlds. Hear from leading edge companies who have successfully launched products in this area, from research lab oratories developing cutting edge science in support of this area, smaller companies launching novel tests, the FDAs guidelines on developing products in this area and feedback from Clinical Directors at reference, specialty, service, or central laboratories who ultimately use these tests.